BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION

Generic: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Leading PharmaManufacturer
OPHTHALMICRoute
BRIMONIDINE TARTRATEActive Substance
2025-02-25Original Approval

BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION is FDA application ANDA219093, sponsored by CAPLIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
EYE PAIN
292 reports
2
EYE IRRITATION
227 reports
3
FATIGUE
208 reports
4
DRUG INEFFECTIVE
206 reports
5
OCULAR HYPERAEMIA
186 reports
6
HEADACHE
185 reports
7
VISION BLURRED
174 reports
8
OFF LABEL USE
162 reports
9
PRODUCT DOSE OMISSION ISSUE
140 reports
10
DIZZINESS
137 reports